OpenEvidence Physician-First Distribution

This was a distribution hack that turned a hard hospital software sale into a simple doctor habit. A physician could open OpenEvidence like a medical search app, ask a question, and get cited answers without IT approval, budget signoff, or patient data access. That let the company spread by word of mouth among clinicians first, then use that installed user base to justify deeper hospital deals and EHR workflow expansion later.1 2 3 4

• The real barrier was not teaching doctors the product, it was avoiding the hospital buying process. OpenEvidence was built to be free and initially outside the patient record, while incumbent UpToDate has long been sold mainly through institutions and enterprises, which means slower top down procurement and formal contracting.1 5
• That bottom up motion created leverage. Internal research ties the no records, no payment setup to rapid adoption among U.S. physicians, then to a later move into HIPAA secure products, enterprise contracts, and EHR connected workflows such as scribes, calling, and in app clinical support.1 2 3
• The closest comparison is Doximity. Both companies grew by winning physician attention before selling more deeply into workflow and monetization. But Doximity centered on communication and pharma marketing, while OpenEvidence started with clinical question answering and then expanded outward into workflow tools.2 6

The next step is clear. Physician level adoption becomes the wedge for becoming embedded software inside care delivery, where the product moves from optional reference tool to daily system of action inside the chart, the note, and the patient call. That is where hospital budgets, switching costs, and long term defensibility get much stronger.2 3 4